Manchester Capital Management’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-13
Closed -$1K – 660
2020
Q4
$1K Buy
13
+7
+117% +$336 ﹤0.01% 636
2020
Q3
$0 Buy
+6
New +$250 ﹤0.01% 563
2016
Q1
– Sell
-5,100
Closed -$124K – 604
2015
Q4
$124K Hold
5,100
– – 0.02% 274
2015
Q3
$84K Buy
+5,100
New +$99.1K 0.01% 322
2015
Q1
– Sell
-5,300
Closed -$104K – 583
2014
Q4
$104K Sell
5,300
-5,100
-49% -$98.1K 0.01% 531
2014
Q3
$193K Buy
10,400
+200
+2% +$4.28K 0.03% 352
2014
Q2
$248K Hold
10,200
– – 0.03% 310
2014
Q1
$232K Buy
10,200
+5,100
+100% +$111K 0.04% 301
2013
Q4
$101K Hold
5,100
– – 0.02% 477
2013
Q3
$105K Hold
5,100
– – 0.02% 459
2013
Q2
$82K Buy
+5,100
New +$88.2K 0.02% 482

Other funds holding BRKR

Manchester Capital Management's BRKR Position: Q1 2021 in Review

Manchester Capital Management sold out of Bruker (BRKR) in Q1 2021, closing a stake of 13 shares — an estimated $1K sold.

Manchester Capital Management first reported a position in BRKR in Q2 2013 and held it in 11 quarters. The position peaked at $248K in Q2 2014. 246 funds tracked by Wall St. Rank hold BRKR as of Q1 2021.

  • Manchester Capital Management reported no remaining Bruker position as of Q1 2021 after selling out during the quarter.
  • Manchester Capital Management sold 13 Bruker shares in Q1 2021, an estimated $1K.
  • Manchester Capital Management first reported a position in Bruker in Q2 2013 and held it in 11 quarters.
  • Manchester Capital Management's Bruker position peaked at $248K in Q2 2014.
  • 246 funds tracked by Wall St. Rank held Bruker as of Q1 2021.

Based on Manchester Capital Management's 13F filing for Q1 2021, filed 13 May 2021.